A Food and Drug Administration advisory panel Friday afternoon voted against recommending the approval of booster doses of a COVID-19 vaccine for the general public, saying it needed more data. But the group unanimously approved a second, narrower recommendation for booster shots for older adults and individuals at high risk for severe disease, including healthcare workers.